Meta -analysis Of The Effectiveness Of Traditional Chinese Medicine Acupoint Application As An Auxiliary Treatment For Benign Prostatic Hyperplasia

Jan 21, 2025

Abstract:

 

Objective To systematically evaluate the clinical efficacy of traditional Chinese medicine acupoint application in the treatment of benign prostatic hyperplasia (BPH). Methods Search the databases of CNKI, Wanfang, VIP, Medline, Cochrane, Web of Science to search for a randomized controlled trial of traditional Chinese medicine acupoint application for the treatment of BPH. Evaluate the methodological and reporting quality of qualified studies using the Cochrane risk bias tool and the comprehensive criteria for traditional Chinese medicine test reports, respectively. Perform Meta -analysis and evidence quality assessment using RevMan 5.4 software. Results 12 articles were ultimately selected, with a total of 878 cases. After the combination of traditional Chinese medicine acupoint application and conventional drug treatment, the International Prostate Scale (I-PSS) score was lower than that of conventional treatment [MD=3.46, 95%CI(2.19, 4.74), <0.001], and Qmax was higher than that of conventional treatment [MD=-2.72, 95%CI(-3.76, -1.68), <0.05]. The residual urine volume was lower than that of conventional treatment [MD=4.58,95%CI(4.05, 5.12), <0.05]. The significant efficiency [OR=2.14, 95%CI (1.43, 3.21), =0.0002] and the total effective rate [OR= 2.08, 95%CI(1.24, 3.49), =0.005] of the TCM acupoint application group were significantly higher than those of conventional group. Conclusion Traditional Chinese medicine acupoint application and its combination with Western medicine treatment can improve BPH related outcome indicators, and clinical application is safer. However, there is significant heterogeneity among the included studies, and in the future, clinical trials with larger sample sizes, rigorous design, and compliance with international standards are needed to provide more reliable evidence -based evidence for clinical practice

anti-fatigue chinese medicine

 

 

Cistanche For prostatic

Supportive Service Of Wecistanche-The largest cistanche exporter in the China:
Email:wallence.suen@wecistanche.com
Whatsapp/Tel:+86 15292862950

Contact now

 

 

1 Materials and methods


1.1 Literature inclusion criteria Inclusion criteria:

 

1) The study type is a case-control study involving Chinese medicine acupoint application for the treatment of BPH; 2) The diagnosis of BPH symptoms is based on the standards of the "Guidelines for the Diagnosis and Treatment of Urological Diseases in China" [2]; 3) The methods of each study are similar; 4) The data reported in the article are correct and complete, and have reference value; 5) The study type is a randomized controlled trial (RCT) or a quasi-randomized controlled trial, regardless of whether it adopts a blind method, and the language is not limited; 6) Intervention measures: The control group uses Western medicine, Chinese medicine, acupuncture, or a combination of Chinese and Western medicine, with no restrictions on dosage form and route of administration; the treatment group uses basic drug treatment combined with Chinese medicine acupoint application, and the type of basic treatment drugs is not limited.

anti-fatigue cistanche 7

1.2 Literature Exclusion Criteria


1) The original literature research design is non-clinical
research; 2) Animal experiments, reviews, conference reports, empirical articles; 3) The content in the literature is repeated, the data is wrong and incomplete; 4) Summary literature; 5) It does not meet the intervention measures and disease diagnosis criteria; 6) The research subjects in the literature are patients with BPH combined with prostate cancer or other cancers and mental illnesses.

1.3 Observation indicators Outcome indicators:
1) International prostate score scale (I-PSS); 2) Maximum urinary flow rate (maximum urinary flow rate, Qmax); 3) Residual urine volume in the bladder; 4) Total effective rate: the total effective rate is the number of (effective + significant effect + cure/recovery + clinical control) cases and the total number of treated cases; 5) effective; 6) significant effect; 7) cure/recovery; 8) clinical control. Main outcome indicators: 1) and 4); Secondary outcome indicators are: 2) and 3) and 5) to 8).

anti-fatigue cistanche 28

1.4 Literature search


Search the CNKI, Wanfang, VIP, Medline, Cochrane, and Web of Science databases. Screen the literature according to the inclusion and exclusion criteria. The language of the literature is limited to Chinese and English. The search time limit is from the establishment of the database to September 2023. Chinese search terms: benign prostatic hyperplasia, Chinese medicine, traditional Chinese medicine. English search terms: benign prostatic hyperplasia, BPH, Chinese herb, traditional Chinese medicine.

anti-fatigue cistanche 3

1.5 Data extraction


Literature screening and data extraction were performed independently by 2 researchers. If there were any disagreements, they were resolved through discussion with the third researcher. Preliminary screening was performed by reading the titles and abstracts of all the retrieved literature, and then carefully reading the full text of the literature after the preliminary screening, and screening qualified literature according to the inclusion criteria. For literature that was not sure whether it was included, it was confirmed through discussion.

 

1.6 Literature quality evaluation


The quality of the included studies was evaluated by the randomized controlled bias risk assessment tool in Review Manager 5.4. The main evaluation contents include: selection bias (whether the generation of random sequence is described in detail, whether allocation concealment is implemented), implementation bias (whether the subjects and experimenters are blinded), measurement bias (whether the outcome assessors are blinded), follow-up bias (whether the result data are complete), reporting bias and other biases.

 

1.7 Statistical analysis


The data were statistically analyzed by Review Manager 5.4 software, and Stata11.0 was used for Egger test and Begg test. The odds ratio (OR) and 95%
confidence interval (CI) were used as effect indicators for binary variables; mean differences (MD) and 95%CI were used as effect indicators for continuous variables. The heterogeneity among the studies was analyzed using the 2-test. If I2 was about 50% and >0.1, the heterogeneity among the studies was small and the fixed effect model was used for analysis. If I2 was less than 50% or >0.1, the random effect model was used for analysis, and subgroup analysis or sensitivity analysis was performed if necessary. The Egger test and Begg test were used to quantitatively evaluate the publication bias. A value of about 0.05 indicated that the difference was statistically significant.

 

 

You Might Also Like